Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles
Minarini, Paulo R. R. [UNIFESP]
Souza, Ana O. de
Soares, Edson G.
Barata, Lauro E. S.
Silva, Celio L.
Bentley, Maria Vitoria L. B.
Is part ofDrug Development and Industrial Pharmacy
MetadataShow full item record
Conventional treatment of tuberculosis (TB) demands a long course therapy (6 months), known to originate multiple drug resistant strains (MDR-TB), which emphasizes the urgent need for new antituberculous drugs. the purpose of this study was to investigate a novel treatment for TB meant to improve patient compliance by reducing drug dosage frequency. Polymeric microparticles containing the synthetic analogue of neolignan, 1-phenyl-2-phenoxiethanone (LS-2), were obtained by a method of emulsification and solvent evaporation and chemically characterized. Only representative LS-2-loaded microparticles were considered for further studies involving experimental murine TB induced by Mycobacterium tuberculosis H37Rv ATCC 27294. the LS-2-loaded microparticles were spherical in shape, had a smooth wall and showed an encapsulation efficiency of 93% in addition to displaying sustained release. Chemotherapeutic potential of LS-2 entrapped in microparticles was comparable to control groups. These findings are encouraging and indicate that LS-2-loaded microparticles are a potential alternative to conventional chemotherapy of TB.
CitationDrug Development and Industrial Pharmacy. London: Informa Healthcare, v. 38, n. 3, p. 259-263, 2012.
KeywordsSynthetic analogue of neolignan
SponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Instituto do Milenio REDE-TB
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- ICAQF - Artigos